Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Candela

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To understand the frequency of facial and scalp hyperhidrosis
To understand the pathophysiology of facial and scalp hyperhidrosis
To discuss science and results of RFM treatment for hyperhidrosis

Introduction: Facial and scalp hyperhidrosis is a debilitating condition with very few treatment options. There has been success using RFM for axillary hyperhidrosis. It would make sense to apply RFM to treat facial and scalp hyperhidrosis.

Materials / method: Patients were examined with ultrasound to determine skin thickness in areas of treatment. Depths of RFM were chosen to be at or slightly below level of dermal/sub q junction. Patients were treated with energy levels to destroy the eccrine and apocrine glands. 2 treatments at least were performed.

Results: Patient satisfaction was high. Approximately 40% improvement with one treatment and 60% improvement with 2 treatments. Results lasted at least a year in most cases.

Conclusion: Facial and scalp hyperhidrosis can be treated successfully with RFM. Ultrasound is a good adjunct to determine best depths. Patient satisfaction is high and results are long lasting.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To demonstrate that CO2 LASER keeps staying the Gold standard of Dermatology equipment because it is the most versatil, quick and efficacious of all LASERs and EBDs.
CO2 Laser was first discovered in 1961 as a surgical tool and evolved over the years with the introduction of the fractional mode and recently with the handpieces that allow gynecological treatments.

Introduction: The CO2 LASER, with his excellent absorption by the water, capacity of thermic coagulation, different type of pulses (continuous, pulsed) and with his 3 different modes: surgical, fractional and gynecological, make him a fantastic tool to improve dozens of clinical dermatological conditions as much as aesthetical ones. In the surgical mode, his narrow diameter, precise beam and coagulation capacity allows a precise cut and vaporization without bleeding, with destruction of a plethora of dermatological lesions from the most small and benign (mília) to the bigger ones like basocelular carcinoma

Materials / method: In the fractional mode, with the different shapes and deeps of penetration performed by the scanner piece, allows work like a resurfacing tool on the skin in benign (laser peel) , in complex conditions (scars, burns, deep wrinkles) and as a efficacious Drug Delivery Device in medical conditions (melasma, alopecias,onicomicosis, psoriasis, actinic, keratosis, skin cancer...) as much as aesthetical conditions (photoaging, spots, pós inflammatory pigmentation, delivery of antioxidants, hyaluronic acid, PLLA,...).

Results: In the gynecological mode, beyond the vaporization and/or external resurfacing of the vulva, the gynecological laser handpiece improves conditions like vaginal atrophy and stress urinary incontinence. Lastly, the fractional mode is being applied on skin inflammatory conditions with chronic pruritus, fibrosis, pain and paresthesias with very interesting results.

Conclusion: Despite the countless LASERs and EBDs available in the market, the CO2 LASER remains the Gold standard to every dermatological clinic.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability